Heterotypic contact reveals a COX-2-mediated suppression of osteoblast differentiation by endothelial cells: A negative modulatory role for prostanoids in VEGF-mediated cell: cell communication?

Experimental Cell Research

Volumn 314, Issue 17, 2008, Pages 3152-3161

  Clarkin, Claire E ^a   Garonna, Elena ^a   Pitsillides, Andrew A ^a   Wheeler Jones, Caroline P D ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Cell differentiation; Cell proliferation; Cell: cell communication; COX 2; Endothelial cell; Osteoblast; PGE2; VEGF; VEGFR

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN H2; PROSTANOID; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; BIOLOGICAL MODEL; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CROSS LINKING; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; REGULATORY MECHANISM;

EID: 53049092440     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.07.027     Document Type: Article

References (45)

1. Akarasereenont P., Techatraisak K., Thaworn A., and Chotewuttakorn S. The induction of cyclooxygenase-2 by 17 beta-estradiol in endothelial cells is mediated through protein kinase C. Inflamm. Res. 49 (2000) 460-465
2. Kage K., Fujita N., Oh-hara T., Ogata E., Fujita T., and Tsuruo T. Basic fibroblast growth factor induces cyclooxygenase-2 expression in endothelial cells derived from bone. Biochem. Bioph. Res. Comm. 254 (1999) 259-263
3. Houliston R.A., Keogh R.J., Sugden D., Dudhia J., Carter T.D., and Wheeler-Jones C.P.D. Protease-activated receptors upregulate cyclooxygenase-2 expression in human endothelial cells. J. Thromb. Haemost. 88 (2002) 321-328
4. He H., Venema V.J., Gu X., Venema R.C., Marrero M.B., and Caldwell R.B. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src. J. Biol. Chem. 274 (1999) 25130-25135 H
5. Hernandez G.L., Volpert O.V., Iniguez M.A., Lorenzo E., Martinez-Martinez S., Grau R., Fresno M., and Redondo J.M. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J. Exp. Med. 193 (2001) 607-620
6. Tamura M., Sebastian S., Gurates B., Yang S., Fang Z., and Bulun S.E. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. J. Clin. Endocrinol. Metab. 87 (2002) 3504-3507
7. Marcus A.J., Weksler B.B., and Jaffe E.A. Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells. J. Biol. Chem. 253 (1978) 7138-7141
8. Camacho M., Lopez-Belmonte J., and Vila L. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity. Circ. Res. 83 (1998) 353-365
9. Leahy K.M., Koki A.T., and Masferrer J.L. Role of cyclooxygenases in angiogenesis. Curr. Med. Chem. 7 (2000) 1163-1170
10. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 19 (2000) 19-27
11. Gately S., and Li W. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin. Oncol. 31 (2004) 2-11
12. Amano H., Haysahi I., Yoshida S., Yoshimura H., and Majima M. Cyclooxygenase-2 and adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Human Cell 15 (2002) 13-24
13. Rao R., Redha R., Macias-Perez I., Su Y., Hao C., Zent R., Breyer M.D., and Pozzi A. Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J. Biol. Chem. 282 (2007) 16959-16968
14. Cianchi F., Cortesini C., Bechi P., Fantappie O., Messerini L., Vannacci A., Sardi I., Baroni G., Boddi V., Mazzanti R., and Masini E. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 121 (2001) 1339-1347 F
15. Geiger F., Bertram H., Berger I., Lorenz H., Wall O., Eckhardt C., Simank H.-G., and Richter W. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J. Bone Miner. Res. 20 (2005) 2028-2035
16. Eckardt H., Ding M., Lind M., Hansen E., Christensen K., and Hvid I. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J. Bone Joint Surg. 87 (2005) 1434-1438
17. Tatu T., Sipola A., Jämsä T., Soini Y., Ylä-Herttuala S., Tuukkanen J., and Hautala T. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J. Gene Med. 5 (2003) 560-566
18. Simon A., Manigrasso M., and JP O.C. Cyclo-oxygenase 2 function is essential for bone fracture healing. J. Bone Miner. Res. 17 (2002) 963-976
19. Clarkin C.E., Emery R.J., Pitsillides A.A., and Wheeler-Jones C.P.D. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J. Cell. Physiol. 214 (2008) 537-544
20. Fitch J.L., Kotton D.N., Gerstensfeld L.C., and Einhorn T.A. Osteogenic and angiogenic cell lineages show differential responsiveness to angiogenic signals. 54th Annual Meeting of the Orthopaedic Research Society vol. 33 (2008), San Franscisco 001
21. Houliston R.A., and Wheeler-Jones C.P.D. sPLA2 cooperates with cPLA2 alpha to regulate prostacyclin synthesis in human endothelial cells. Biochem. Bioph. Res. Comm. 287 (2001) 881-887
22. Zaman G., Pitsillides A.A., Rawlinson S.C., Suswillo R.F., Mosley J.R., Cheng M.Z., Platts L.A., Hukkanen M., Polak J.M., and Lanyon L.E. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J. Bone Miner. Res. 14 (1999) 1123-1131
23. Wheeler-Jones C.P.D., Abu-Ghazaleh R., and Cospedal R. Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen activated kinase. FEBS Lett. 353 (1997) 503-512
24. Williams C.S., Mann M., and DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18 (1999) 7908-7916
25. Wang Y., Wan C., Gilbert S.R., and Clemens T.L. Oxygen sensing and osteogenesis. Ann. N.Y. Acad. Sci. 1117 (2007) 1-11
26. Pai R., Soreghan B., Szabo I.I., Pavelka M., Baatar D., and Tarnawski A. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nature 8 (2002) 289-293
27. Donnini S., Finetti F., Solito R., Terzuoli E., Sacchetti A., Morbidelli L., Patrignani P., and Ziche M. EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways. FASEB J. 21 (2007) 2418-2430
28. Buchanan F.G., Wang D., Bargiacchi F., and DuBois R.N. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J. Biol. Chem. 278 (2003) 35451-35457
29. Finetti F., Solito R., Morbidelli L., Giachetti A., Ziche M., and Donnini S. Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1. J. Biol. Chem. 283 (2008) 2139-2146
30. Mahadev K., Wu X., Donnelly S., Ouedraogo R., Eckhart A.D., and Goldstein B.J. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc. Res. 78 (2008) 376-384
31. Lu J., Lu Z., Reinach P., Zhang J., Dai W., Lu L., and Xu M. TGF-[beta]2 inhibits AKT activation and FGF-2-induced corneal endothelial cell proliferation. Exp. Cell. Res. 312 (2006) 3631-3640
32. Kang S.S., Li T., Xu D., Reinach P.S., and Lu L. Inhibitory effect of PGE2 on EGF induced MAP kinase activity and rabbit corneal epithelial proliferation. Invest. Ophthalmol. Vis. Sci. 41 (2000) 2164-2169
33. Tang H., Wang J., Bai F., Zhai H., Gao J., Hong L., Xie H., Zhang F., Lan M., Yao W., Liu J., Wu K., and Fan D. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer. Cancer Invest. 26 (2008) 60-67
34. Kolev Y., Uetake H., Iida S., Ishikawa T., Kawano T., and Sugihara K. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann. Surg. Oncol. 14 (2007) 2738-2747
35. Da M.X., Wu X.T., Wang J., Guo T.-K., Zhao Z.-G., Luo T., Zhang M.-M., and Qian K. Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer. Arch. Med. Res. 39 (2008) 92-99
36. Deasy B.M., O'Sullivan-Coyne G., O'Donovan T.R., McKenna S.L., and O'Sullivan G.C. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E2-independent mechanisms. Cancer Lett. 256 (2007) 246-258
37. Hua Zhong M.W.J.S. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms. Inter. J. Cancer 112 (2004) 585-595
38. Needleman P., Bronson S.D., Wyche A., Sivakoff M., and Nicolaou K.C. Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues. J. Clin. Inves. 61 (1978) 839-849
39. Morinelli T.A., Zhang L.M., Newman W.H., and Meier K.E. Thromboxane A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J. Biol. Chem. 269 (1994) 5693-5698
40. Duka I., Duka A., Kintsurashvili E., Johns C., Gavras I., and Gavras H. Mechanisms mediating the vasoactive effects of the B1 receptors of bradykinin. Hypertension 42 (2003) 1021-1025
41. Michel F., Silvestre J.-S., Waeckel L., Corda S., Verbeuren T., Vilaine J.P., Clergue M., Duriez M., and Levy B.I. Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 488-493
42. Keeting P.E., Dong D.S., Fu S.C., and Lysz T.W. Rat lens prostaglandin generation proceeds by the non-enzymatic degradation of PGH2 endoperoxide. Exp. Eye Res. 44 (1987) 261-268
43. Stafford J.B., and Marnett L.J. Prostaglandin E2 inhibits tumor necrosis factor-alpha RNA through PKA type I. Biochem. Bioph. Res. Comm. 366 (2008) 104-109
44. Kanno Y., Ishisaki A., Yoshida M., Tokuda H., Numata O., and Kozawa O. SAPK/JNK plays a role in transforming growth factor-beta-induced VEGF synthesis in osteoblasts. Horm. Metab. Res. 37 (2005) 140-145
45. Wang C., Gilbert S.R., Wang Y., Cao X., Shen X., Ramaswamy G., Jacobsen K.A., Alaql Z.S., Eberhardt A.W., Gerstenfeld L.C., Einhorn T.A., Deng L., and Clemens T.L. Activation of the hypoxia-inducible factor-1(alpha) pathway accelerates bone regeneration. Proc. Natl. Acad. Sci. 105 (2008) 686-691